Red Herring Editor Jumps Into New Overhyped Trend: Biotech

from the follow-the-hype-trail dept

Jason Pontin, former high profile editor of the now out of business Red Herring, has moved onto a new gig, as editor of a new magazine about the biotech industry. Yes, this sounds like someone moving from one overhyped industry into another - but Pontin insists he's learned his lessons from Red Herring, and the magazine, the Acumen Journal, won't make the same mistakes. It's easy to say that early on, of course.
Hide this

Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.

Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.

While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.

–The Techdirt Team


Reader Comments

Subscribe: RSS

View by: Time | Thread


  • identicon
    dorpus, 14 May 2003 @ 11:17pm

    Heh

    Biological sciences have a chronic oversupply of brilliant PhD's chasing their dreams, working for low salaries. Biotech places premium value on the researchers' scientific accomplishments. IT support for them, in the form of bioinformatics, is a relatively trivial support role (despite its claimed importance). And there is already an oversupply of brilliant bioinformatics experts with at least masters degrees. It is not the next dot com hiring boom for IT techies.

    In pharmaceutical research, 99.9% of research fails. The 0.1% that succeeds is handed off to production, so the researchers lose their jobs anyway. If you want to go into the biotech industry, you're looking at a life of bouncing from one failed company to the next. Unless you have a PhD in biology, and unless you think that squiggly molecules are the purpose of your life, it is not a fulfilling career.


    link to this | view in chronology ]


Follow Techdirt
Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Discord

The latest chatter on the Techdirt Insider Discord channel...

Loading...
Recent Stories

This site, like most other sites on the web, uses cookies. For more information, see our privacy policy. Got it
Close

Email This

This feature is only available to registered users. Register or sign in to use it.